TMBIM6 antagonist-1  ≥98%

促销价¥{{model.attbuying.price}}

市场价¥0.00

累计销量0 累计评价0 人评论

别称 {{model.alias}}
中文名称 {{model.name}}
英文名称 {{model.enname}}
品牌 {{model.brand}}
CAS {{model.cas}}
分子式
分子量 {{model.molecularweight}}
MDL {{model.mdl}}
货号 {{model.procode}}
数量

+ -

库存{{model.attbuying.number}}
包装规格:5mg 10mg 50mg 100mg in glass bottle
溶解性:溶于DMSO(50mg/mL超声)
产品描述:基本信息 产品编号: T11483 产品名称: TMBIM6 antagonist-1 CAS: 123134-61-2   储存条件 粉末 -20℃ 四年     分子式: C15H12N2O3 溶于液体 -80℃ 6个月 分子量: 268.27 -20℃ 1个月 化学名:  1-(2-Aminophenyl)-3-(3-nitrophenyl)prop-2-en-1-one Solubility (25°C):   体外:   DMSO   Ethanol   Water   体内(现配现用):   <1mg/ml表示微溶或不溶。 普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。   制备储备液   浓度   溶液体积 质量   1mg   5mg   10mg 1mM 3.7276mL 18.6379mL 37.2759mL 5mM 0.7455mL 3.7276mL 7.4552mL 10mM 0.3728mL 1.8638mL 3.7276mL   生物活性 产品描述 一个有潜力的TMBIM6拮抗剂,抑制TMBIM6与mTORC2结合,降低 mTORC2活性,调节TMBIM6释放Ca2+。 靶点 mTOR   体外研究 TMBIM6 antagonist-1 (BIA,0.5-10μM,3 days) significantly and dose-dependently inhibits cell viability in HT1080,MCF7,MDAMB-2341 and SKBR3 cells,with IC50 values of 1.7±0.1μM for HT1080,2.6±0.4μM for MCF cells,2.6±0.5μM for MDA-MB-231 cells,and 2.4±0.4μM for SKBR3 cells,respectively.TMBIM6 antagonist-1 (BIA,10μM) treatment decreases cell migration in HT1080,MCF7,MDA-MB-231,and SKBR3 cells,not TMBIM6 KO HT1080 cells. Cell Viability Assay Cell Line: HT1080,MCF7,MDA-MB-2341 and SKBR3 cells. Concentration: 0.5-10μM. Incubation Time: 3 days. Result: Inhibited cell viability. Western Blot Analysis Cell Line: WT and TMBIM6 KO HT1080 cells. Concentration: 0,2,5μM. Result: Downregulated the protein levels of AKT-pS473. 体内研究 TMBIM6 antagonist-1 (1mg/kg,IP 5 days per week during 25 days) significantly impaires cell-driven tumor growth. Animal Model: Six- to eight-week BklNbt:BALB/c/nu/nu old mice (HT1080 and MDA-MB-231 cells). Dosage: 1mg/kg. Administration: IP 5 days per week during 25 days. Result: Impaired cell-driven tumor growth.
保存条件:-20℃